What triggered Injective's latest price pullback

Traders Union
All News
Crypto News
Injective slips 10.21% today to $5.15

Highlights

INJ/USD is under short-term selling pressure, trading below its 20-day moving average after a 10.21% drop today.
Mixed momentum: MACD is bullish and ADX signals a strong trend, but oscillators show oversold conditions and intraday weakness.
INJ/USD is likely to consolidate between $4.81 and $5.66 over the next five days, with equal probability of breakout or further downside.

Anton Kharitonov, expert at Traders Union, notes the short-term bearish structure as INJ fails to hold above its 20-day moving average. He sees little support from the broader trend given the lack of positive catalysts and the daily drop of 10.21%. The analyst highlights that momentum divergences suggest an unstable setup. Oscillator readings showing oversold do not outweigh persistent selling. "With no supportive news and heavy intraday losses, I see limited reasons for optimism at these levels," Kharitonov concludes.

Viktoras Karapetjanc, expert at Traders Union, remains constructive on INJ’s medium-term outlook, noting that the price still holds above the 50- and 200-day moving averages. He believes the bullish structure remains intact despite short-term volatility and a lack of fresh news. The expert emphasizes the robust trend strength reflected in the ADX and resilient RSI. "I expect this market to offer recovery opportunities, especially if buyers defend the $4.81 support region," Karapetjanc states.

Bearish short-term momentum amid mixed daily technical signals

INJ/USD has dropped to $5.15, trading below its 20-day moving average ($5.76), but still above its 50-day ($4.76) and 200-day ($4.21) moving averages, suggesting short-term bearishness with medium- and long-term support intact. The nearest dynamic resistance is seen at the Ichimoku Kijun level around $5.89. Momentum signals are mixed: the Moving Average Convergence Divergence (MACD) remains firmly bullish on the daily timeframe, and the Average Directional Index (ADX) indicates strong trend strength. However, the Relative Strength Index (RSI) sits near midline with a buy forecast, and the Stochastic RSI signals oversold, joined by the Commodity Channel Index (CCI) also bordering on oversold. Bull/Bear Power (BBP) shows buyers have slight dominance, but intraday readings and oscillators lean negative. The pair opened with a downside gap near $0.18 and is trading near the session lows, having fallen 10.21% today with volatility at 6.49%. Overall tone shows continued sell pressure after the open. There is notable divergence between daily momentum and oscillator signals, as short-term buying interest fails to overcome heavy intraday selling.

Previously it was reported that Injective shifted to a bearish technical profile, with analysts highlighting increased downside risk amid intensifying sell momentum. With current signals still pointing to heightened intraday volatility and mixed momentum across timeframes, traders should closely monitor the $4.81 support as a potential inflection point for near-term price action.

Source of Data: INJ Price Analysis by TU

The analysis is based on a proprietary model combining technical, on-chain, and expert data. Not investment advice. See methodology

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.